Plain-English translation of NCT06802939 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing repetitive transcranial magnetic stimulation (rTMS) โ a non-invasive brain stimulation procedure โ to treat persistent auditory hallucinations (hearing voices) in people with schizophrenia. Before treatment begins, researchers use a special brain-imaging scan to identify the exact brain regions causing your hallucinations, so the stimulation can be personalized just for you. Then you'll receive this treatment over several weeks to see if it reduces or stops the voices.
Many people with schizophrenia continue to hear voices even after taking multiple antipsychotic medications. This trial is exploring whether personalized brain stimulation โ targeted to each person's unique brain patterns โ might help those for whom current medications aren't working well enough.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
First, you'll undergo a specialized brain scan (magnetoencephalography) while resting and during a task to map where your hallucinations originate. Then you'll receive two weeks of sham (fake) stimulation to establish a baseline. After a two-week rest, you'll receive real brain stimulation treatment for two weeks (5 days per week), targeting 2 to 4 brain locations per day, with each session lasting about 23 minutes. After that, you'll return for follow-up evaluations at 7, 14, 30, 60, and 90 days to track your progress.
AI-generated summary from trial data ยท Jun 2, 2026 ยท Not medical advice
China